Watabe et al. [70] have identified the E3 ubiquitin ligase Praja 1 (PJA1), which is capable of preventing the formation of neuronal TDP-43 aggregates, and therefore, it has been postulated as a potential therapeutic target for ALS. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.